PedAM
Pediatric Disease Annotations & Medicines
| Disease | osteoporosis |
| Phenotype | C0011849|diabetes mellitus |
| Sentences | 15 |
| PubMedID- 25797364 | Bone quality indicators closely related to bone fragility are required to be identified to establish a diagnostic method for osteoporosis in patients with diabetes mellitus. |
| PubMedID- 22168267 | The exclusion criteria are: 1) known medical conditions or other physical problems that need special attention in an exercise program (e.g., history of myocardial infarction, angioplasty, or angina, admission to the hospital for evaluation of chest pain, use of nitroglycerin to treat angina, uncontrolled hypertension, diabetes mellitus with insulin treatment, osteoporosis, or under active treatment for cancer); 2) planning an international trip during the next four months (subjects are required to upload mobile phone data to a server daily, and will not be able to do so from abroad); 3) pregnant/delivered a baby during the past six months; 4) known severe hearing or speech problem; 5) history of eating disorder (e.g. |
| PubMedID- 24348809 | Insulin deficiency accelerates bone loss and is potentially the main cause of osteoporosis in patients with type 1 diabetes mellitus (15). |
| PubMedID- 22932297 | Therapeutic strategy for osteoporosis in patients with diabetes mellitus]. |
| PubMedID- 25895468 | Clinical issue: diabetic bone diseases are more than just osteoporosis in patients with diabetes mellitus (dm): a relatively high bone mineral density is paired with a paradoxically high risk of fragility fractures. |
| PubMedID- 25617479 | In conclusion, l-arginine and soy enriched diet are effective in prevention of osteoporosis associated with diabetes mellitus. |
| PubMedID- 21594681 | Since type 2 diabetes mellitus is a cause of secondary osteoporosis in the general population, in this cross-sectional study we aimed at investigating the association between diabetes mellitus and vertebral fractures in males with acromegaly. |
| PubMedID- 20190361 | Bone quality more markedly contributes to bone strength in osteoporosis associated with diabetes mellitus than without it. |
| PubMedID- 23961320 | Biomolecular basis of the role of diabetes mellitus in osteoporosis and bone fractures. |
| PubMedID- 22932296 | How to start drug therapy for osteoporosis in patients with diabetes mellitus]. |
| PubMedID- 23953046 | Methods: in 103 postmenopausal women (mean age 57.0 years, 95% ci 50.0-64.0) with mild to moderate risk of cvd (score<5), no more than mild hypertension, normal function of thyroid gland, without coronary artery disease, diabetes mellitus and secondary causes of osteoporosis pulse wave velocity between carotid and femoral sites (cfpwv, by applanation tonometry) and ankle and brachial sites (bapwv, by volume sphygmography) as well as bone mineral density at lumbar spine and femoral neck (by dual-energy x-ray absorptiometry) and blood serum levels of markers of bone turnover (total procollagen type i amino-terminal propeptide (pinp), osteocalcin, collagen type 1 cross-linked c-telopeptide (-ctx) by electrochemilumininescence immunoassay) were assessed. |
| PubMedID- 21772974 | osteoporosis in men with diabetes mellitus. |
| PubMedID- 23833577 | This study was conducted to evaluate the relationship between osteoporosis and osteopenia with type 2 diabetes mellitus (dm) in postmenopausal women. |
| PubMedID- 26078704 | Each model has its own advantages, disadvantages and scope of use30, 31. this study used a rat model of diabetes mellitus combined with osteoporosis established using intralipid and a small dose of streptozotocin. |
| PubMedID- 21537459 | osteoporosis in diabetes mellitus: possible cellular and molecular mechanisms. |
Page: 1